Patent 11970482 was granted and assigned to Ligand Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.
Disclosed herein are acetal and cyclic acetal compounds, compositions, their preparation, and their uses. Some embodiments relate to their use as liver-targeting compounds.